PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1400993
PUBLISHER: AnalystView Market Insights | PRODUCT CODE: 1400993
Cell Cryopreservation Market size was valued at USD 8,778 Million in 2022, expanding at a CAGR of 20.5% from 2023 to 2030.
Cell cryopreservation is a technique utilized to preserve cells at extremely low temperatures, typically ranging from -80°C to -196°C, in order to maintain their viability for extended periods of time. This method is widely employed in diverse fields such as medicine, research, and biotechnology, with the purpose of storing cells for future use or experiments. Extensive developmental work has been conducted to ensure the successful cryopreservation and resuscitation of various cell lines belonging to different cell types. The fundamental principle behind achieving successful cryopreservation and resuscitation lies in a gradual freezing process followed by a rapid thawing process. The primary objective of cryopreservation is to prevent cellular damage caused by the formation of ice crystals, dehydration, and other freezing-related factors. Furthermore, Cell cryopreservation plays a pivotal role in numerous fields by facilitating the long-term storage and retrieval of cells, thereby contributing to advancements in medicine, biotechnology, and scientific research.
Cell Cryopreservation Market- Market Dynamics
Increasing research and development of stem cells and rise in the number of biobanks are expected to drive the growth of Cell Cryopreservation market
The demand for cell cryopreservation technologies is directly impacted by the growth of stem cell research. Stem cells are commonly cryopreserved to ensure their viability for future use, and the progress in stem cell therapies drives the necessity for efficient cryopreservation solutions. A significant majority of respondents, approximately 70 percent, express their support for medical research that utilizes stem cells from human embryos. Furthermore, a smaller majority, around 54 percent, believe that the existing lines of embryonic stem cells approved by President Bush for federal funding are insufficient for research requirements. The donor registry currently holds nearly 268,000 cord blood units, including over 111,000 units from the National Cord Blood Inventory (NCBI). In 2022 alone, more than 3,000 NCBI units were added, as reported by the Health Resource and Service Administration. Moreover, the establishment and expansion of biobanks worldwide contribute to the increasing demand for advanced cryopreservation techniques. Additionally, ongoing advancements in cryopreservation techniques, such as enhanced cry protectants, automated systems, and innovative freezing methods, present opportunities for market growth. However, the limited awareness and education regarding the benefits of cell cryopreservation, particularly in developing regions, can impede market expansion.
Cell Cryopreservation Market- Key Insights
As per the analysis shared by our research analyst, the global Cell Cryopreservation market is estimated to grow annually at a CAGR of around 20.5% over the forecast period (2023-2030)
Based on Product segmentation, Cryopreservation media was predicted to show maximum market share in the year 2022
Based on application segmentation, Stem cells was the leading type in 2022
Based on End-User segmentation, Pharmaceutical and biotechnology company was the leading type in 2022
On the basis of region, North America was the leading revenue generator in 2022
The Global Cell Cryopreservation Market is segmented on the basis of Product, Application, End-User, and Region.
The market is divided into two categories based on Product: Cryopreservation media and equipment. Cryopreservation media have become the dominant force in the market. These solutions are specifically formulated to safeguard cells from any harm that may occur during the freezing and thawing process. The rising interest in regenerative medicine and cell-based therapies has resulted in a higher need for cryopreservation media that can effectively preserve the quality of therapeutic cells.
The market is divided into two categories based on application: Stem cells, Oocytes cells, Sperm cells and Others. Stem cells hold a prominent position in the market, with cryopreservation media specifically tailored to cater to the distinctive traits and susceptibilities of these cells. These media are typically formulated with cry protective agents that are finely tuned to ensure optimal preservation of stem cells.
The market is divided into two categories based on End-User: Pharmaceutical and biotechnology company, Research institute and Others. The market is dominated by pharmaceutical and biotechnology companies. Cryopreserved cells are frequently utilized by these companies during the drug discovery process. Stem cell research is often pursued by these companies to create innovative therapies. The preservation of stem cells through cryopreservation is essential for maintaining their viability and functionality in regenerative medicine and cell-based therapies.
Cell Cryopreservation Market- Geographical Insights
Geographically, this market is spread across North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided based on the countries involved in business activities. The growth of the market is expected to be dominated by North America, primarily due to the rise in research and development (R&D) activities in the pharmaceutical and biotechnical industries. North America, especially the United States, is known for its strong and advanced pharmaceutical and biotechnical sector. The region is home to numerous biotech companies, pharmaceutical manufacturers, and research institutions that are actively engaged in extensive R&D endeavors. The U.S. pharmaceutical industry generated USD 550 billion in revenue in 2021. The U.S. is expected to spend USD605-USD635 billion on medicine in 2025, according to Pharmaceutical Statistics & Demographics. Europe holds the second-largest market during the forecast period, primarily driven by the increasing demand for in vitro fertilization (IVF) procedures.
The cell cryopreservation market is highly competitive, with a strong emphasis on technological advancements, strategic collaborations, and the development of cryopreservation technologies for various applications. Companies in this market are continuously investing in research and development to introduce innovative cryopreservation technologies that improve cell viability and functionality after thawing. In certain cases, pharmaceutical and biotechnology companies may opt to outsource cryopreservation services to specialized providers with expertise in cell banking and preservation technologies. The increasing focus on personalized medicine, including individualized cell therapies, underscores the significance of reliable cryopreservation solutions in the pharmaceutical and biotechnology sectors. As an example, Thermo Fisher Scientific Inc., a global leader in scientific services, and the University of California, San Francisco (UCSF), have joined forces to accelerate advanced cell therapies for challenging conditions such as cancer, rare diseases, and other illnesses. This collaboration will take place at a newly established cGMP manufacturing facility located near UCSF Medical Center's Mission Bay campus.
In February 2022, Global provider of cryopreservation, cell culture, and respiratory products OriGen Biomedical, Inc., announced the introduction of its new CryoStoreTM FLEX Freezing Bag in the United States and Europe. For the CryoStoreTM FLEX Freezing Bag product line, OriGen has received CE mark approval, proving that it complies with key EU Medical Device Directives. OriGen aspires to supply top-notch medical equipment to enhance patients' well-being and facilitates transformative treatments globally.
The scope of this report covers the market by its major segments, which include as follows: